These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps. Vuralkan E, Saka C, Akin I, Hucumenoglu S, Unal BU, Kuran G, Ocal B. Ther Adv Respir Dis; 2012 Feb; 6(1):5-10. PubMed ID: 22042749 [Abstract] [Full Text] [Related]
13. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Spangler DL, Abelson MB, Ober A, Gotnes PJ. Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132 [Abstract] [Full Text] [Related]
14. Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children. Chur V, Small CB, Stryszak P, Teper A. Pediatr Allergy Immunol; 2013 Feb; 24(1):33-8. PubMed ID: 23331528 [Abstract] [Full Text] [Related]
18. Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis. Bernstein DI, Teper A, Gopalan G, Gates D. Ann Allergy Asthma Immunol; 2012 May; 108(5):359-62. PubMed ID: 22541408 [Abstract] [Full Text] [Related]